Recombinant 3-oxosteroid 1-dehydrogenase (kstD), partial

Shipped with Ice Packs
In Stock

Description

Molecular and Biochemical Characteristics

Structural Features
The kstD enzyme (EC 1.3.99.4) is a flavoprotein that uses flavin adenine dinucleotide (FAD) as a cofactor . Its crystal structure reveals a soluble, monomeric protein with a flavin-binding domain, facilitating electron transfer during catalysis . Recombinant variants are typically engineered via heterologous expression in hosts such as Escherichia coli, Corynebacterium crenatum, or Bacillus species .

Substrate Specificity
Recombinant kstD enzymes exhibit broad substrate spectra, including hydrocortisone, 4-androstene-3,17-dione (AD), and 9α-hydroxy-4-androstene-3,17-dione (9α-OH-AD) . Notably, the PrKstD variant from Propionibacterium sp. achieved 92.5% conversion of hydrocortisone to prednisolone at 80 g/L substrate concentration , while MsKstD1 from Mycobacterium smegmatis showed high affinity for 9α-OH-AD (Km = 36.9 µM) .

Catalytic Mechanism and Reaction Optimization

Reaction Pathway
The enzyme catalyzes the Δ1-dehydrogenation of 3-ketosteroids, introducing a double bond between C1 and C2 via a vicinal dehydrogenation mechanism. This step is critical for subsequent steroid nucleus degradation or transformation .

Optimization Parameters

  • pH and Temperature: Optimal activity occurs at pH 7.0–8.5 and 30–40°C .

  • Electron Acceptors: Phenazine methosulfate (PMS) and 2,6-dichlorophenolindophenol (DCPIP) enhance FAD regeneration .

  • Co-Solvents: Methanol (2–5% v/v) improves substrate solubility without inhibiting activity .

Industrial Applications in Biotechnology

Pharmaceutical Steroid Production
Recombinant kstD enzymes are pivotal in synthesizing Δ1-3-ketosteroids, such as prednisolone (from hydrocortisone) and androst-1,4-diene-3,17-dione (ADD) . These intermediates are precursors for corticosteroids and contraceptives.

Strain Engineering
Genetic engineering strategies include codon optimization (e.g., Corynebacterium crenatum for Mycobacterium neoaurum kstD) and overexpression of kstD in industrial hosts like E. coli .

Fermentation Processes
Whole-cell biocatalysis using resting E. coli cells (50 g/L wet weight) achieved 90% conversion of hydrocortisone to prednisolone within 3 hours .

Host Systems for Recombinant Production

Host OrganismKey FeaturesPerformance
E. coli BL21(DE3)High expression yield, scalable92.5% conversion of hydrocortisone
Corynebacterium crenatumNative steroid catabolism pathways1.6-fold increased kstD expression post-codon optimization
Bacillus sp.Thermotolerant, robust growthEnables Δ1-dehydrogenation at elevated temperatures

Challenges and Future Directions

Technical Limitations

  • Reduced activity in complex substrates (e.g., C6-substituted steroids) .

  • Electron acceptor costs in large-scale processes .

Innovation Opportunities

  • Engineering kstD variants with expanded substrate tolerance .

  • Coupling kstD with cofactor regeneration systems for isolated enzyme applications .

Product Specs

Form
Lyophilized powder. Note: We will prioritize shipping the format we have in stock. If you have special format requirements, please specify them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery information. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize developing it.
Synonyms
kstD; Rv3537; 3-oxosteroid 1-dehydrogenase; EC 1.3.99.4; 3-keto-Delta(4)-steroid Delta(1)-dehydrogenase; KSDD; 3-oxo-Delta(4)-steroid 1-dehydrogenase; KSTD
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Target Names
kstD
Uniprot No.

Target Background

Function
Involved in cholesterol degradation. Catalyzes the removal of hydrogen atoms at C-1 and C-2 of the A-ring from the polycyclic ring structure of 3-ketosteroids. Shows preference for 3-ketosteroids with a saturated A-ring, with highest activity on 5α-AD (5α-androstane-3,17-dione) and 5α-T (5α-testosterone, also known as 17β-hydroxy-5α-androstane-3-one). Also involved in converting 3-keto-4-ene-steroids to 3-keto-1,4-diene-steroids. Catalyzes the conversion of 3-oxo-23,24-bisnorchol-4-en-22-oyl-coenzyme A thioester (4-BNC-CoA) to 3-oxo-23,24-bisnorchola-1,4-dien-22-oyl-coenzyme A thioester (1,4-BNC-CoA).
Gene References Into Functions
1. The kstD mutant strain, unable to utilize cholesterol for carbon and energy, has limited replication within resting human macrophages post-infection. (PMID: 23425360) 2. Cloning and biochemical characterization (PMID: 18031290)
Database Links

KEGG: mtu:Rv3537

STRING: 83332.Rv3537

Protein Families
FAD-dependent oxidoreductase 2 family, 3-oxosteroid dehydrogenase subfamily

Q&A

What is 3-oxosteroid 1-dehydrogenase (kstD) and what reaction does it catalyze?

3-oxosteroid 1-dehydrogenase (kstD), also known as 3-ketosteroid Δ1-dehydrogenase, is an enzyme belonging to the family of oxidoreductases that act on the CH-CH group of donors with other acceptors. The enzyme catalyzes the introduction of a double bond between the C-1 and C-2 atoms of 3-ketosteroids. The systematic name for this enzyme is 3-oxosteroid:acceptor Δ1-oxidoreductase (EC 1.3.99.4). The reaction can be represented as:

3-oxosteroid + acceptor → 3-oxo-Δ1-steroid + reduced acceptor

This reaction is essential in the degradation pathway of steroids, as the introduction of the C-1/C-2 double bond represents an integral step needed for cholestane A-ring aromatization and subsequent B-ring opening . The Δ1-dehydrogenation is a critical step in the microbial catabolism of steroid compounds.

What organisms naturally express kstD and what is its physiological role?

The kstD enzyme has been identified and characterized in several bacterial species, with the most extensively studied being Rhodococcus erythropolis. Other microorganisms known to express kstD include Mycobacterium fortuitum and various Rhodococcus strains. In these organisms, kstD plays a crucial physiological role in steroid degradation pathways, allowing the bacteria to utilize steroids as carbon and energy sources .

The introduction of a 1(2)-double bond into the steroid nucleus by Δ1-KSTD constitutes an essential step in microbial steroid degradation . This enzyme, working in conjunction with other steroid-degrading enzymes such as cholesterol-3-OH-dehydrogenase (CholD) and 3-ketosteroid-9α-hydroxylase (Kst-9αH), facilitates the breakdown of the steroid ring structure, particularly when a hydroxyl is added at C-9 to Δ1-Δ4-3-ketosteroids, causing the B ring to become unstable and spontaneously open .

What are the different isoenzymes of kstD and how do they differ?

Research has identified multiple kstD isoenzymes in several bacterial species with distinct substrate specificities and catalytic properties. In Rhodococcus erythropolis SQ1, three Δ1-KSTD isoenzymes have been characterized:

IsoenzymePreferred SubstratesCharacteristics
Δ1-KSTD19-OHAD (9α-hydroxy-4-androstene-3,17-dione)Broad substrate range
Δ1-KSTD2AD (4-androstene-3,17-dione)Broad substrate range
Δ1-KSTD35α-androstane-3,17-dione and 5α-testosteroneNarrow substrate specificity

In Mycobacterium fortuitum ATCC 6842, two different Δ1-KSTDs have been identified, depending on the steroid inducers applied. When induced with AD, a membrane-associated Δ1-KSTD with higher activity toward AD than toward 9-OHAD is expressed. In contrast, when induced with 9α-hydroxyprogesterone, the bacterium expresses a soluble Δ1-KSTD with higher activity on 9-OHAD than on AD .

These isoenzymes appear to have evolved to accommodate different steroid substrates, allowing bacteria to efficiently metabolize a variety of steroid compounds found in their environment.

How can gene disruption techniques be applied to study kstD function?

Gene disruption techniques have proven valuable for understanding kstD function and its role in steroid degradation pathways. Research on R. erythropolis SQ1 has demonstrated two effective approaches for kstD gene disruption:

  • Targeted disruption using antibiotic resistance markers: This method involves creating a disruption vector containing an antibiotic resistance gene (such as aphII for kanamycin resistance) and an internal fragment of the kstD gene. For example, in R. erythropolis SQ1, the plasmid pSDH420 containing a 741-bp Asp718/SalI kstD internal fragment was used for targeted disruption of kstD, resulting in loss of more than 99% of the KSTD activity .

  • Unmarked gene deletion using counter-selectable markers: This more sophisticated approach allows for the creation of clean deletions without introducing antibiotic resistance genes. Using the sacB counter-selection system, researchers achieved unmarked deletion of the kstD gene in R. erythropolis SQ1. The process involved conjugative mobilization of the mutagenic plasmid from Escherichia coli S17-1 to R. erythropolis to avoid random genomic integration .

The kstD gene deletion mutant of R. erythropolis SQ1, designated strain RG1, retained approximately 10% of the KSTD enzyme activity of the wild-type strain and was still able to grow on steroid substrates such as AD and 9OHAD. This led to the discovery of a second KSTD enzyme (KSTD2) in R. erythropolis SQ1, demonstrating how gene disruption techniques can reveal previously unknown enzyme redundancy .

What methods are effective for heterologous expression of recombinant kstD?

Heterologous expression of recombinant kstD has been successfully achieved using several strategies. The following methodological approaches have proven effective:

  • E. coli expression systems: The kstD gene from R. erythropolis SQ1 has been successfully expressed in E. coli under the control of the lac promoter. This system yields functional 3-ketosteroid Δ1-dehydrogenase activity, although optimization may be required for high-level expression .

  • PCR amplification and cloning strategy: For effective cloning, specific primers targeting the 5′ end (including start codon) and 3′ end (including stop codon) of the kstD gene can be designed. For example, the kstD gene from R. erythropolis was amplified using the following PCR conditions:

    • 5 cycles of 1 min at 95°C, 1.5 min at 60°C, and 1.5 min at 72°C

    • Followed by 25 cycles of 1 min at 95°C, 1.5 min at 55°C, and 1.5 min at 72°C

  • Expression vector selection: The pET3 expression system (Novagen) with T7 RNA polymerase has been used for kstD expression, incorporating NdeI and BamHI restriction sites in the primers for directional cloning .

  • Human cell line expression: Research has demonstrated that kstD can also be stably expressed in human cell lines such as Hep3B and U-937, where it maintains its ability to introduce a double bond between the C-1 and C-2 atoms of 3-ketosteroids. This approach is particularly valuable for studying potential biotechnological applications in mammalian systems .

How can kstD activity be measured and characterized in vitro?

Several analytical methods have been developed to measure and characterize kstD activity in vitro:

  • Reverse-phase high-performance liquid chromatography (RP-HPLC): This method allows for the separation and quantification of substrate and product steroids based on their hydrophobicity. RP-HPLC can be used to measure the ability of Δ1-KstD to introduce a double bond between C-1 and C-2 of steroid substrates .

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS): This more sensitive technique combines the separation capabilities of HPLC with the detection specificity of mass spectrometry, allowing for definitive identification and quantification of steroid metabolites. LC-MS/MS is particularly useful for detecting subtle changes in steroid structure resulting from kstD activity .

  • Spectrophotometric assays: These assays can measure kstD activity based on the reduction of artificial electron acceptors such as 2,6-dichlorophenolindophenol. The progress of the reaction can be monitored by the decrease in absorbance at specific wavelengths.

  • Bioconversion assays: These involve incubating purified enzyme or whole cells expressing kstD with steroid substrates and analyzing the conversion products. For example, the RG1-UV29 strain (lacking both KSTD1 and KSTD2) was shown to stoichiometrically convert AD into 9OHAD in concentrations as high as 20 g/L, demonstrating the biotransformation capabilities in the absence of kstD activity .

For accurate determination of enzyme kinetics, researchers should consider factors such as substrate solubility, potential inhibition at high substrate concentrations, and the selection of appropriate cofactors or electron acceptors.

What are the functional implications of multiple kstD isoenzymes in bacterial steroid degradation?

The presence of multiple kstD isoenzymes in bacteria like R. erythropolis has significant functional implications for steroid degradation:

  • Substrate range expansion: Different isoenzymes exhibit distinct substrate preferences, collectively enabling the bacterium to degrade a wider range of steroid compounds. For example, while Δ1-KSTD1 and Δ1-KSTD2 have broad substrate ranges with preferences for 9-OHAD and AD respectively, Δ1-KSTD3 specifically targets 5α-androstane-3,17-dione and 5α-testosterone .

  • Functional redundancy: Gene disruption studies have revealed that multiple kstD genes can compensate for each other's loss. In R. erythropolis SQ1, disruption of the kstD gene (encoding KSTD1) did not abolish growth on steroid substrates like AD or 9α-hydroxy-4-androstene-3,17-dione, indicating that other isoenzymes (like KSTD2) could fulfill the same function .

  • Specialized metabolic roles: The substrate specificity patterns suggest evolutionary adaptation to different ecological niches or metabolic scenarios. The inducibility of different isoenzymes by specific steroid compounds further supports this specialization .

  • Sequential degradation pathway optimization: The combined action of multiple kstD isoenzymes, along with other steroid-degrading enzymes, allows for efficient progression through the steroid degradation pathway. This enables bacteria to completely mineralize steroid compounds for energy and carbon utilization.

These functional aspects were elegantly demonstrated in the strain RG1-UV29, which had lost all KSTD enzyme activity (both KSTD1 and KSTD2) and consequently was unable to grow on either AD or 9OHAD. This strain stoichiometrically converted AD into 9OHAD, indicating that both isoenzymes function in AD and 9OHAD catabolism .

What transformation and electroporation protocols are effective for Rhodococcus species?

Effective transformation of Rhodococcus species, particularly for genetic manipulation of kstD genes, requires optimized protocols due to the challenging nature of introducing foreign DNA into these bacteria. The following methodology has been successfully employed:

  • Electroporation protocol for R. erythropolis SQ1:

    • Grow cells to mid-exponential phase (OD600 ≈ 0.8-1.0)

    • Wash cells multiple times with ice-cold electroporation buffer

    • Resuspend cells in a small volume of buffer with DNA

    • Apply electric pulse (optimized parameters: 2.5 kV, 25 μF, 400 Ω)

    • Add 1 ml of LBP medium immediately after the electropulse

    • Incubate cell suspension for 4.5 hours with shaking

    • Plate appropriate dilutions on selective media

Using this protocol, transformation frequencies as high as 10^6 transformants per μg of DNA have been achieved with plasmids like pMVS301 .

  • Antibiotic selection markers:

    • For plasmid pDA71: Chloramphenicol (40 μg/ml)

    • For plasmid pMVS301: Thiostrepton (10 μg/ml)

    • For gene disruption with pSDH420: Kanamycin (200 μg/ml)

  • Conjugative mobilization:

    • To avoid random genomic integration, conjugative mobilization of mutagenic plasmids from E. coli S17-1 to R. erythropolis has proven effective

    • This approach is particularly valuable when using the sacB counter-selection system for unmarked gene deletion

Transformants typically appear after approximately 3 days of incubation, and successful transformation can be verified by PCR amplification of the target gene or by assessing enzyme activity.

How can PCR-based methods be optimized for kstD amplification and analysis?

PCR-based methods for kstD amplification and analysis can be optimized using the following approaches:

  • Colony PCR for Rhodococcus:

    • Resuspend a single Rhodococcus colony in 25 μl of TE buffer (10 mM Tris–1 mM EDTA)

    • Heat for 10 min in boiling water to lyse cells

    • Use 1-2 μl of this lysate as template in PCR reactions

  • Primer design for kstD amplification:

    • Include restriction sites compatible with expression vectors (e.g., NdeI and BamHI for pET3 system)

    • Ensure primers anneal to the 5′ end (including start codon) and 3′ end (including stop codon) of the kstD gene

    • Example primers for R. erythropolis kstD:

      • Forward: 5′ GCGCATATGCAGGACTGGACCAGCGAGTGC (includes NdeI site)

      • Reverse: 5′ GCGGGATCCGCGTTACTTCGCCATGTCCTG (includes BamHI site)

  • Optimized PCR conditions for kstD amplification:

    • Initial cycles: 5 cycles of 1 min at 95°C, 1.5 min at 60°C, and 1.5 min at 72°C

    • Main amplification: 25 cycles of 1 min at 95°C, 1.5 min at 55°C, and 1.5 min at 72°C

    • This two-step approach with higher annealing temperature in initial cycles helps improve specificity

  • Hybridization analysis:

    • For Southern blot verification, labeled kstD probes can be hybridized at 60°C

    • Stringent washing (60°C) should be performed in 2× SSC containing 0.1% (wt/vol) SDS (twice for 5 min each time) and in 0.1× SSC with 0.1% (wt/vol) SDS (twice for 5 min each time)

These optimized PCR-based methods can be used for kstD gene identification, cloning, verification of gene disruption or deletion, and analysis of gene expression under different conditions.

What strategies can be employed for constructing unmarked gene deletion mutants in Rhodococcus species?

The construction of unmarked gene deletion mutants in Rhodococcus species, particularly for kstD genes, can be accomplished using the following strategic approach:

  • sacB counter-selection system:

    • The sacB gene from Bacillus subtilis encodes levansucrase, which produces a polymer toxic to many gram-positive bacteria when grown in the presence of sucrose

    • This system allows for selection of double crossover events that result in loss of both the sacB gene and the antibiotic resistance marker

  • Construction of the mutagenic plasmid:

    • Include homologous regions flanking the target kstD gene

    • Incorporate the sacB gene as a counter-selectable marker

    • Include an antibiotic resistance gene for initial selection of transformants

  • Conjugative mobilization:

    • Transfer the mutagenic plasmid from E. coli S17-1 to R. erythropolis via conjugation

    • This approach helps avoid random genomic integration of the plasmid

  • Two-step selection process:

    • First selection: Identify transformants containing the integrated plasmid using antibiotic resistance

    • Second selection: Plate transformants on media containing sucrose to select for loss of the sacB gene through a second recombination event

    • Screen resulting colonies for loss of the target gene

This method was successfully used to create the first unmarked gene deletion mutants in Rhodococcus, specifically the kstD gene deletion mutant of R. erythropolis SQ1 (strain RG1). This approach is valuable because it allows for the creation of mutants without permanent introduction of antibiotic resistance markers, which is particularly useful for subsequent genetic manipulations of the same strain .

What analytical methods are most suitable for characterizing kstD enzyme activity and substrate specificity?

Several analytical methods have proven effective for characterizing kstD enzyme activity and substrate specificity:

  • Reverse-phase high-performance liquid chromatography (RP-HPLC):

    • Allows separation and quantification of steroid substrates and products

    • Can detect the introduction of a double bond between C-1 and C-2 of 3-ketosteroids

    • Useful for monitoring reaction progress and determining conversion rates

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS):

    • Provides definitive identification of reaction products based on mass spectra

    • Can detect and quantify minor metabolites

    • Allows for structural confirmation of steroid transformations

  • Enzyme kinetics analysis:

    • Determination of Km and Vmax values for different substrates

    • Comparison of catalytic efficiency (kcat/Km) across substrates and enzyme variants

    • Analysis of inhibition patterns and substrate specificity profiles

  • Whole-cell bioconversion assays:

    • Measurement of substrate conversion and product formation by intact cells expressing kstD

    • Particularly valuable for biotechnological applications

    • Can be scaled up for larger bioconversion experiments (demonstrated with conversions at concentrations as high as 20 g/L)

  • Comparative analysis of wild-type and mutant strains:

    • Comparison of growth rates on different steroid substrates

    • Analysis of metabolite profiles during steroid degradation

    • Assessment of enzyme activity in cell-free extracts

The choice of analytical method depends on the specific research question, available equipment, and the nature of the substrates and products being studied. For comprehensive characterization, a combination of these methods is often most effective.

What are the potential biotechnological applications of recombinant kstD?

Recombinant 3-oxosteroid 1-dehydrogenase (kstD) offers several promising biotechnological applications:

  • Production of pharmaceutical steroid intermediates:

    • The ability of kstD to introduce a specific double bond in the steroid nucleus makes it valuable for the synthesis of steroid drugs

    • When expressed in combination with other steroid-modifying enzymes, it can facilitate the production of complex steroid derivatives with specific biological activities

  • Bioremediation of steroid-containing waste:

    • Recombinant bacteria expressing kstD can be used to degrade environmental steroid pollutants

    • The enzyme's role in steroid ring degradation makes it an essential component of bioremediation strategies

  • Analytical tools for steroid detection:

    • Enzyme-based assays utilizing kstD can be developed for detecting and quantifying steroids in environmental or biological samples

    • Such assays could offer advantages in specificity compared to traditional chemical methods

  • Whole-cell biocatalysts for steroid transformations:

    • Engineered strains with modified kstD expression can perform specific bioconversions

    • For example, the RG1-UV29 strain (lacking both KSTD1 and KSTD2) stoichiometrically converted AD into 9OHAD in concentrations as high as 20 g/L, demonstrating potential for industrial-scale bioconversions

  • Synthetic biology applications:

    • Integration of kstD into synthetic pathways for novel steroid production

    • Development of biosensors for steroid detection based on kstD activity

The strategic manipulation of kstD genes, either through deletion, overexpression, or enzyme engineering, offers opportunities to develop biotechnological processes with applications in pharmaceutical, environmental, and analytical fields.

What challenges remain in understanding the structure-function relationship of kstD enzymes?

Despite significant advances in kstD research, several challenges remain in understanding the structure-function relationship of these enzymes:

  • Limited structural information:

    • The three-dimensional structure of kstD enzymes has not been fully elucidated

    • Crystallographic studies are needed to determine the exact structural features that govern substrate binding and catalysis

    • Understanding the structural basis for differences in substrate specificity among isoenzymes remains incomplete

  • Mechanism of electron transfer:

    • The precise mechanism by which electrons are transferred from the substrate to the acceptor during catalysis needs further investigation

    • The identity and role of physiological electron acceptors in vivo remain to be fully characterized

  • Regulation of kstD gene expression:

    • The mechanisms controlling the differential expression of kstD isoenzymes in response to various steroid inducers are not fully understood

    • Transcriptional and post-transcriptional regulatory networks affecting kstD expression need further characterization

  • Evolutionary relationships:

    • The evolutionary history and selective pressures that led to the diversification of kstD isoenzymes across bacterial species remain to be elucidated

    • Comparative genomic and phylogenetic analyses could provide insights into these evolutionary relationships

  • Integration with other steroid-degrading enzymes:

    • The coordination of kstD activity with other enzymes in the steroid degradation pathway, such as 3-ketosteroid-9α-hydroxylase (Kst-9αH), requires further investigation

    • Understanding these interactions is essential for developing efficient biocatalytic systems

Addressing these challenges will require a combination of structural biology, biochemistry, molecular genetics, and systems biology approaches. Such research will not only advance our understanding of steroid metabolism but also enable the development of more effective biotechnological applications utilizing kstD enzymes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.